Cancer immunotherapy Authors Stefano Vella Direttore, Dipartimento del Farmaco, Istituto Superiore di Sanità, Roma - Italy DOI: https://doi.org/10.33393/grhta.2016.305 Keywords: Immunoterapia, Cancer Abstract No abstract
Downloads PDF (Italian) ePub How to Cite Vella, S. (2019). Cancer immunotherapy. Global and Regional Health Technology Assessment, 3(Suppl. 1), S1-S2. https://doi.org/10.33393/grhta.2016.305 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 3 No. Suppl. 1 (2016): Suppl. 1 - Farmaci oncologici e sostenibilità Section Editorial (on invitation only) License Copyright (c) 2019 The authors This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Metrics Statistics Abstract views - 749 times PDF (Italian) downloads - 626 times ePub downloads - 260 times Sign up Browse Sections Health Technology Assessment Health Policies banners150 0.8 2023CiteScore 28th percentile Powered by Completed peer reviews since:November 4, 2020 Most popular articles in the last 30 days Optimising pediatric paracetamol and ibuprofen use: a retrospective study with expert evaluation of efficacy, safety, and healthcare costs 193 Health technology assessment of an automated unitdose drug distribution system in a high-specialization national referral hospital of the Italian National Health Service 167 Differences in organizational impact, performance and quality related to the use of single- and/or reusable bronchoscopes in anesthesiology and resuscitation 161 Cooperation among stakeholders for the sustainability of the new pharmaceutical paradigm in Italy 154 Diagnostic and therapeutic approach to the ACS patient 133